Association of Receipt of Systemic Treatment for Melanoma With Insurance Type in North Carolina.

ABSTRACT:

Background

Previous studies of hospital-based patients with metastatic melanoma suggest sociodemographic factors, including insurance type, may be associated with the receipt of systemic treatments.

Objectives

To examine whether insurance type is associated with the receipt of systemic treatment among patients with melanoma in a broad cohort of patients in North Carolina.

Methods

We conducted a retrospective cohort study between 2011 and 2017 of patients with stages III-IV melanoma using data from the North Carolina Central Cancer Registry linked to Medicare, Medicaid, and private health insurance claims across the state. The primary outcome was the receipt of any systemic treatment, and the secondary outcome was the receipt of immunotherapy.

Results

A total of

SUBMITTER: Adamson AS 

PROVIDER: S-EPMC10844879 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature